EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements 08.05.2023 / 12:58 CET/CEST Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed: Report Type: Quarterly financial report within the 1st half-year (Q1) Language: German Date of disclosure: May 15, 2023 Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857 Language: English Date of disclosure: May 15, 2023 Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876 08.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	Dermapharm Holding SE
	Lil-Dagover-Ring 7
	82031 Grünwald
	Germany
Internet:	ir.dermapharm.de

End of News	EQS News Service

1626569  08.05.2023 CET/CEST